Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 26830669 |
US |
91 | 2 |
Dermatitis atopic, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 902 | 26830880 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 903 | 26830883 |
US |
47 | 2 |
Dermatitis atopic, Rash pruritic, Dry skin, |
||||
DUPILUMAB, |
||||
| 904 | 26830884 |
US |
61 | 2 |
Dermatitis atopic, Skin irritation, |
||||
DUPILUMAB, |
||||
| 905 | 26830890 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 906 | 26830896 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 907 | 26830900 |
US |
36 | 2 |
Dermatitis atopic, Dermatitis contact, |
||||
DUPILUMAB, |
||||
| 908 | 26830906 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 909 | 26831220 |
US |
76 | 2 |
Dermatitis atopic, Sunburn, Pain, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 910 | 26831232 |
US |
22 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 911 | 26831244 |
US |
75 | 1 |
Dermatitis atopic, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 912 | 26831249 |
US |
37 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 913 | 26831376 |
US |
72 | |
Visual impairment, Dermatitis atopic, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 914 | 26831464 |
US |
2 | |
Dermatitis atopic, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 915 | 26831527 |
US |
66 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 916 | 26831529 |
US |
18 | 2 |
Dermatitis atopic, Pruritus, Dry skin, Dermatitis, Therapeutic response shortened, Off label use, |
||||
DUPILUMAB, |
||||
| 917 | 26831578 |
US |
64 | 2 |
Dermatitis atopic, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 918 | 26831581 |
US |
74 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 919 | 26831817 |
US |
3 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 920 | 26831821 |
US |
14 | 2 |
Dermatitis atopic, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 921 | 26831825 |
US |
1 | |
Dermatitis atopic, Scratch, Skin discolouration, |
||||
DUPILUMAB, |
||||
| 922 | 26831828 |
US |
70 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 923 | 26831831 |
US |
56 | 1 |
Dermatitis atopic, Eczema, Dry skin, Erythema, Discomfort, |
||||
DUPILUMAB, |
||||
| 924 | 26831834 |
US |
40 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 925 | 26831836 |
US |
55 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 926 | 26831861 |
US |
53 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 927 | 26832234 |
US |
7 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 928 | 26832258 |
US |
64 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 929 | 26832262 |
US |
27 | 1 |
Skin weeping, Skin haemorrhage, Dry skin, Pruritus, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 930 | 26832300 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 931 | 26832555 |
US |
2 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 932 | 26832587 |
US |
24 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 933 | 26832590 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 934 | 26832597 |
US |
41 | 2 |
Sensitive skin, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 935 | 26832613 |
US |
41 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 936 | 26832663 |
US |
84 | 1 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 937 | 26832883 |
US |
28 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 938 | 26832895 |
US |
1 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 939 | 26832922 |
US |
20 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 940 | 26832924 |
US |
4 | 1 |
Dermatitis atopic, Blister, Skin lesion, Haemorrhage, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 941 | 26833111 |
US |
80 | |
Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 942 | 26833230 |
US |
23 | 1 |
Dry skin, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 943 | 26833512 |
US |
40 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 944 | 26833514 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 945 | 26833518 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 946 | 26833526 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 947 | 26833912 |
US |
65 | 2 |
Dermatitis atopic, Rash pruritic, |
||||
DUPILUMAB, |
||||
| 948 | 26834188 |
US |
2 | 1 |
Sleep disorder due to a general medical condition, Skin fissures, Dry skin, Skin exfoliation, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 949 | 26834215 |
US |
7 | 2 |
Stress, Tension, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 950 | 26834416 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 951 | 26834424 |
US |
20 | 1 |
Dermatitis atopic, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 952 | 26825240 |
US |
15 | 1 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Asthma, |
||||
DUPILUMAB, DUPILUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 953 | 26825242 |
US |
66 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 954 | 26825630 |
US |
65 | 1 |
Blister, Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 955 | 26825632 |
US |
25 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 956 | 26825634 |
CN |
39 | 2 |
Pneumonia, Anaphylactic reaction, Discomfort, Chest discomfort, Pharyngeal swelling, Dyspnoea, Dermatitis atopic, Intentional dose omission, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 957 | 26825859 |
US |
48 | 2 |
Dermatitis atopic, Skin fissures, Skin haemorrhage, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 958 | 26826105 |
US |
46 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 959 | 26826235 |
JP |
85 | 1 |
Dermatitis exfoliative generalised, Erythema, Pruritus, Dermatitis atopic, Paradoxical skin reaction, |
||||
MEPOLIZUMAB, |
||||
| 960 | 26826359 |
US |
14 | 2 |
Drug ineffective, Dermatitis atopic, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 961 | 26826375 |
US |
36 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 962 | 26826383 |
US |
34 | 1 |
Pruritus, Rash, Therapeutic response shortened, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 963 | 26826661 |
US |
27 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, ATOMOXETINE, PROPRANOLOL HYDROCHLORIDE, METHOCARBAMOL, METHOCARBAMOL TABLETS, CYCLOBENZAPRINE, DESVENLAFAXINE SUCCINATE, |
||||
| 964 | 26826959 |
US |
59 | 1 |
Dermatitis atopic, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 965 | 26826965 |
US |
23 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, HYDROCORTISONE, |
||||
| 966 | 26827682 |
US |
63 | 1 |
Dermatitis atopic, Rash, Skin discomfort, |
||||
DUPILUMAB, |
||||
| 967 | 26827685 |
US |
9 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 968 | 26827693 |
US |
2 | |
Sleep disorder due to a general medical condition, Dermatitis atopic, Asthma, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, EPINEPHRINE, MUPIROCIN, MUPIROCIN CALCIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DROSPIRENONE AND ETHINYL ESTRADIOL, |
||||
| 969 | 26828053 |
US |
63 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 970 | 26828147 |
CO |
19 | 1 |
Cholecystectomy, Dermatitis atopic, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 971 | 26828412 |
US |
20 | 2 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, LEVONORGESTREL, |
||||
| 972 | 26828898 |
US |
44 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 973 | 26828920 |
US |
2 | |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 974 | 26829147 |
US |
2 | |
Dry eye, Eyelid discolouration, Erythema of eyelid, Eyelids pruritus, Paraesthesia, Formication, Eyelid skin dryness, Drug ineffective, Dermatitis atopic, Seasonal allergy, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 975 | 26829274 |
US |
2 | |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, |
||||
| 976 | 26829635 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 977 | 26829703 |
US |
2 | |
Appendicectomy, Dermatitis atopic, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 978 | 26819404 |
US |
65 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 979 | 26819411 |
US |
14 | 1 |
Dermatitis atopic, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 980 | 26819584 |
US |
44 | 1 |
Dermatitis atopic, Pruritus, Skin weeping, Skin haemorrhage, Skin fissures, |
||||
DUPILUMAB, |
||||
| 981 | 26819594 |
US |
13 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 982 | 26819834 |
US |
12 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 983 | 26819839 |
US |
42 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), |
||||
| 984 | 26819841 |
US |
9 | 1 |
Eosinophilic oesophagitis, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 985 | 26819848 |
US |
76 | 1 |
Dermatitis atopic, Pruritus, Skin weeping, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN, PRAVASTATIN SODIUM, SPIRONOLACTONE, TESTOSTERONE CYPIONATE, |
||||
| 986 | 26820096 |
US |
66 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 987 | 26820099 |
US |
45 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 988 | 26820103 |
US |
68 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 989 | 26820114 |
US |
63 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 990 | 26820132 |
US |
36 | 2 |
Dermatitis atopic, Pruritus, Rash, Dry skin, |
||||
DUPILUMAB, |
||||
| 991 | 26820135 |
US |
||
Skin irritation, Dermatitis atopic, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 992 | 26820305 |
US |
33 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 993 | 26820316 |
US |
67 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 994 | 26820317 |
US |
25 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 995 | 26820332 |
US |
53 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 996 | 26820673 |
US |
69 | 2 |
Dermatitis atopic, Skin exfoliation, Dry skin, Skin fissures, |
||||
DUPILUMAB, |
||||
| 997 | 26820696 |
US |
19 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 998 | 26820699 |
US |
46 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 999 | 26821017 |
US |
40 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1000 | 26821022 |
US |
63 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30